Search Results - "Sedić, Mirela"

Refine Results
  1. 1

    Sphingosine 1-Phosphate Signaling and Metabolism in Chemoprevention and Chemoresistance in Colon Cancer by Grbčić, Petra, Sedić, Mirela

    Published in Molecules (Basel, Switzerland) (23-05-2020)
    “…Colorectal carcinoma (CRC) is the leading cause of cancer-related deaths worldwide. Despite advances in prevention and treatment modalities for CRC, rapidly…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Targeting Ceramide Metabolism in Hepatocellular Carcinoma: New Points for Therapeutic Intervention by Grbčić, Petra, Car, Elitza Petkova Markova, Sedić, Mirela

    Published in Current medicinal chemistry (01-01-2020)
    “…Hepatocellular Carcinoma (HCC) is one of the greatest global health burdens because of its uncontrolled cell growth and proliferation, aggressive nature as…”
    Get more information
    Journal Article
  4. 4

    Small Molecules Targeting Biological Clock; A Novel Prospective for Anti-Cancer Drugs by Rahman, Sadia, Wittine, Karlo, Sedić, Mirela, Markova-Car, Elitza P

    Published in Molecules (Basel, Switzerland) (26-10-2020)
    “…The circadian rhythms are an intrinsic timekeeping system that regulates numerous physiological, biochemical, and behavioral processes at intervals of…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Targeting Tumour Metastasis: The Emerging Role of Nanotechnology by Visentin, Sarah, Sedić, Mirela, Pavelić, Sandra Kraljević, Pavelić, Krešimir

    Published in Current medicinal chemistry (01-01-2020)
    “…The metastatic process has still not been completely elucidated, probably due to insufficient knowledge of the underlying mechanisms. Here, we provide an…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11

    Ezrin Inhibition Overcomes Acquired Resistance to Vemurafenib in BRAFV600E-Mutated Colon Cancer and Melanoma Cells In Vitro by Car, Iris, Dittmann, Antje, Vasieva, Olga, Bočkor, Luka, Grbčić, Petra, Piteša, Nikolina, Klobučar, Marko, Kraljević Pavelić, Sandra, Sedić, Mirela

    “…Despite the advancements in targeted therapy for BRAFV600E-mutated metastatic colorectal cancer (mCRC), the development of resistance to BRAFV600E inhibition…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Bioactive Sphingolipids as Biomarkers Predictive of Disease Severity and Treatment Response in Cancer: Current Status and Translational Challenges by Sedić, Mirela, Grbčić, Petra, Pavelić, Sandra Kraljević

    Published in Anticancer research (01-01-2019)
    “…Recent translational studies in cancer have produced a wealth of evidence to support an association between sphingolipid metabolism and clinical outcomes,…”
    Get full text
    Journal Article
  14. 14

    Amidine- and Amidoxime-Substituted Heterocycles: Synthesis, Antiproliferative Evaluations and DNA Binding by Maračić, Silvija, Grbčić, Petra, Shammugam, Suresh, Radić Stojković, Marijana, Pavelić, Krešimir, Sedić, Mirela, Kraljević Pavelić, Sandra, Raić-Malić, Silvana

    Published in Molecules (Basel, Switzerland) (22-11-2021)
    “…The novel 1,2,3-triazolyl-appended N- and O-heterocycles containing amidine 4–11 and amidoxime 12–22 moiety were prepared and evaluated for their…”
    Get full text
    Journal Article
  15. 15

    Novel Bis- and Mono-Pyrrolo[2,3-d]pyrimidine and Purine Derivatives: Synthesis, Computational Analysis and Antiproliferative Evaluation by Bistrović Popov, Andrea, Vianelo, Robert, Grbčić, Petra, Sedić, Mirela, Pavelić, Sandra Kraljević, Pavelić, Krešimir, Raić-Malić, Silvana

    Published in Molecules (Basel, Switzerland) (01-06-2021)
    “…Novel symmetrical bis-pyrrolo[2,3-d]pyrimidines and bis-purines and their monomers were synthesized and evaluated for their antiproliferative activity in human…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Secretome Screening of BRAFV600E-Mutated Colon Cancer Cells Resistant to Vemurafenib by Car, Iris, Dittmann, Antje, Klobučar, Marko, Grbčić, Petra, Kraljević Pavelić, Sandra, Sedić, Mirela

    Published in Biology (Basel, Switzerland) (01-04-2023)
    “…Patients with metastatic colorectal cancer (mCRC) carrying BRAFV600E mutation have worse response to chemotherapy and poor prognosis. The BRAFV600E inhibitor…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Coumarin‐modified ruthenium complexes: Synthesis, characterization, and antiproliferative activity against human cancer cells by Jakopec, Silvio, Hamzic, Lejla F., Bočkor, Luka, Car, Iris, Perić, Berislav, Kirin, Srećko I., Sedić, Mirela, Raić‐Malić, Silvana

    Published in Archiv der Pharmazie (Weinheim) (01-09-2024)
    “…Among ruthenium complexes studied as anticancer metallodrugs, NKP‐1339, NAMI‐A, RM175, and RAPTA‐C have already entered clinical trials due to their potent…”
    Get full text
    Journal Article
  20. 20